{
  "cik": 1739104,
  "cik_padded": "0001739104",
  "entityName": "Elanco Animal Health Inc",
  "fiscal_years": [
    {
      "accn": "0001739104-26-000012",
      "filed": "2026-02-24",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 276000000.0,
        "cash": 545000000.0,
        "cost_of_revenue": 2122000000.0,
        "eps_diluted": -0.47,
        "free_cash_flow": 284000000.0,
        "gross_profit": 2593000000.0,
        "net_income": -232000000.0,
        "operating_cash_flow": 560000000.0,
        "revenue": 4715000000.0,
        "stockholders_equity": 6547000000.0,
        "total_assets": 13358000000.0,
        "total_liabilities": 6811000000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.5499469777306468,
        "leverage": 1.0403238124331755,
        "net_margin": -0.04920466595970307,
        "revenue_growth_yoy": 0.06217616580310881,
        "roa_avg2y": -0.017865393500693053,
        "roa_period_end": -0.017367869441533165,
        "roe_avg2y": -0.03670015028078779,
        "roe_period_end": -0.03543607759279059
      }
    },
    {
      "accn": "0001739104-26-000012",
      "filed": "2026-02-24",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 147000000.0,
        "cash": 468000000.0,
        "cost_of_revenue": 2003000000.0,
        "eps_diluted": 0.68,
        "free_cash_flow": 394000000.0,
        "gross_profit": 2436000000.0,
        "net_income": 338000000.0,
        "operating_cash_flow": 541000000.0,
        "revenue": 4439000000.0,
        "stockholders_equity": 6096000000.0,
        "total_assets": 12614000000.0,
        "total_liabilities": 6518000000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.5487722460013517,
        "leverage": 1.069225721784777,
        "net_margin": 0.07614327551250281,
        "revenue_growth_yoy": 0.00498075616934571,
        "roa_avg2y": 0.025059311981020165,
        "roa_period_end": 0.02679562390994134,
        "roe_avg2y": 0.05487458397597208,
        "roe_period_end": 0.05544619422572179
      }
    },
    {
      "accn": "0001739104-26-000012",
      "filed": "2026-02-24",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 140000000.0,
        "cash": 352000000.0,
        "cost_of_revenue": 1931000000.0,
        "eps_diluted": -2.5,
        "free_cash_flow": 131000000.0,
        "gross_profit": 2486000000.0,
        "net_income": -1231000000.0,
        "operating_cash_flow": 271000000.0,
        "revenue": 4417000000.0,
        "stockholders_equity": 6223000000.0,
        "total_assets": 14362000000.0,
        "total_liabilities": 8139000000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.5628254471360652,
        "leverage": 1.3078900851679254,
        "net_margin": -0.27869594747566223,
        "revenue_growth_yoy": 0.0013602357742008614,
        "roa_avg2y": -0.08247077345660403,
        "roa_period_end": -0.08571229633755745,
        "roe_avg2y": -0.18220840734162227,
        "roe_period_end": -0.1978145588944239
      }
    },
    {
      "accn": "0001739104-26-000012",
      "filed": "2026-02-24",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 171000000.0,
        "cash": 345000000.0,
        "eps_diluted": -0.16,
        "free_cash_flow": 281000000.0,
        "net_income": -78000000.0,
        "operating_cash_flow": 452000000.0,
        "revenue": 4411000000.0,
        "stockholders_equity": 7289000000.0,
        "total_assets": 15491000000.0,
        "total_liabilities": 8202000000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.125257236932364,
        "net_margin": -0.0176830650646112,
        "revenue_growth_yoy": -0.0740973971452561,
        "roa_avg2y": -0.004879727235759642,
        "roa_period_end": -0.005035181718417146,
        "roe_avg2y": -0.010542677569777658,
        "roe_period_end": -0.010701056386335572
      }
    },
    {
      "accn": "0001739104-25-000014",
      "filed": "2025-02-25",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 159000000.0,
        "cash": 638000000.0,
        "eps_diluted": -0.99,
        "free_cash_flow": 324000000.0,
        "net_income": -483000000.0,
        "operating_cash_flow": 483000000.0,
        "revenue": 4764000000.0,
        "stockholders_equity": 7508000000.0,
        "total_assets": 16478000000.0,
        "total_liabilities": 8970000000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.1947256259989345,
        "net_margin": -0.10138539042821158,
        "revenue_growth_yoy": 0.4555453712190651,
        "roa_avg2y": -0.02826958532088613,
        "roa_period_end": -0.02931180968564146,
        "roe_avg2y": -0.060507359849671156,
        "roe_period_end": -0.06433137986148109
      }
    },
    {
      "accn": "0001739104-24-000009",
      "filed": "2024-02-26",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 135000000.0,
        "cash": 495000000.0,
        "eps_diluted": -1.3,
        "free_cash_flow": -176000000.0,
        "net_income": -574000000.0,
        "operating_cash_flow": -41000000.0,
        "revenue": 3273000000.0,
        "stockholders_equity": 8457000000.0,
        "total_assets": 17693000000.0,
        "total_liabilities": 9217000000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.0898663828780892,
        "net_margin": -0.17537427436602504,
        "revenue_growth_yoy": 0.06577661999348747,
        "roa_avg2y": -0.04303042115837294,
        "roa_period_end": -0.03244220878313457,
        "roe_avg2y": -0.082,
        "roe_period_end": -0.06787276812108313
      }
    },
    {
      "accn": "0001739104-23-000004",
      "filed": "2023-03-01",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 140000000.0,
        "cash": 334000000.0,
        "eps_diluted": 0.18,
        "free_cash_flow": 84000000.0,
        "net_income": 68000000.0,
        "operating_cash_flow": 224000000.0,
        "revenue": 3071000000.0,
        "stockholders_equity": 5543000000.0,
        "total_assets": 8985800000.0,
        "total_liabilities": 3438900000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.620404113296049,
        "net_margin": 0.022142624552263106,
        "revenue_growth_yoy": 0.0013695056736663623,
        "roa_avg2y": 0.007579768705587292,
        "roa_period_end": 0.007567495381602083,
        "roe_avg2y": 0.01266294227188082,
        "roe_period_end": 0.012267725058632509
      }
    },
    {
      "accn": "0001739104-22-000005",
      "filed": "2022-02-28",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 134500000.0,
        "cash": 474800000.0,
        "eps_diluted": 0.28,
        "free_cash_flow": 352800000.0,
        "net_income": 86500000.0,
        "operating_cash_flow": 487300000.0,
        "revenue": 3066800000.0,
        "stockholders_equity": 5197000000.0,
        "total_assets": 8956700000.0,
        "total_liabilities": 3759200000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.7233403886857802,
        "net_margin": 0.02820529542193818,
        "revenue_growth_yoy": 0.061543786777431636,
        "roa_avg2y": 0.00966642454042577,
        "roa_period_end": 0.009657574776424352,
        "roe_avg2y": 0.013330970232636989,
        "roe_period_end": 0.01664421781797191
      }
    },
    {
      "accn": "0001739104-21-000004",
      "filed": "2021-03-01",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 98600000.0,
        "cash": 323400000.0,
        "eps_diluted": -1.06,
        "free_cash_flow": 75200000.0,
        "net_income": -310700000.0,
        "operating_cash_flow": 173800000.0,
        "revenue": 2889000000.0,
        "stockholders_equity": 7780300000.0,
        "total_assets": 8940300000.0,
        "total_liabilities": 1160000000.0
      },
      "period_end": "2017-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.14909450792385898,
        "net_margin": -0.10754586362062996,
        "revenue_growth_yoy": -0.008409129912476403,
        "roa_period_end": -0.03475274878919052,
        "roe_avg2y": -0.041993012427606995,
        "roe_period_end": -0.03993419276891637
      }
    },
    {
      "accn": "0001739104-20-000005",
      "filed": "2020-02-28",
      "fiscal_year": 2016,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "capex": 110300000.0,
        "free_cash_flow": 45600000.0,
        "net_income": -47900000.0,
        "operating_cash_flow": 155900000.0,
        "revenue": 2913500000.0,
        "stockholders_equity": 7017400000.0
      },
      "period_end": "2016-12-31",
      "ratio_units": {
        "net_margin": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "net_margin": -0.016440707053372233,
        "roe_period_end": -0.00682588993074358
      }
    }
  ],
  "latest_filing": {
    "accn": "0001739104-26-000012",
    "filed": "2026-02-24",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001739104.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001739104.json"
  },
  "ticker": "ELAN"
}
